VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $220,000 | +120.0% | 10,800 | +4.9% | 0.00% | – |
| Q1 2020 | $100,000 | -45.9% | 10,300 | -8.8% | 0.00% | – |
| Q4 2019 | $185,000 | -50.3% | 11,300 | -57.2% | 0.00% | -100.0% |
| Q2 2019 | $372,000 | -67.0% | 26,400 | -56.9% | 0.00% | -75.0% |
| Q1 2019 | $1,126,000 | -1.8% | 61,193 | +36.9% | 0.00% | +33.3% |
| Q4 2018 | $1,147,000 | +244.4% | 44,700 | +208.3% | 0.00% | +200.0% |
| Q3 2018 | $333,000 | -23.8% | 14,500 | -44.0% | 0.00% | 0.0% |
| Q2 2018 | $437,000 | 0.0% | 25,900 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $437,000 | -1.6% | 25,900 | -6.8% | 0.00% | -50.0% |
| Q4 2016 | $444,000 | -56.6% | 27,800 | -55.8% | 0.00% | -50.0% |
| Q3 2016 | $1,023,000 | +88.4% | 62,900 | +28.7% | 0.00% | +33.3% |
| Q2 2016 | $543,000 | – | 48,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |